1. Home
  2. VALN vs AVAH Comparison

VALN vs AVAH Comparison

Compare VALN & AVAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VALN
  • AVAH
  • Stock Information
  • Founded
  • VALN 2012
  • AVAH 1984
  • Country
  • VALN France
  • AVAH United States
  • Employees
  • VALN N/A
  • AVAH N/A
  • Industry
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • AVAH Hospital/Nursing Management
  • Sector
  • VALN Health Care
  • AVAH Health Care
  • Exchange
  • VALN Nasdaq
  • AVAH Nasdaq
  • Market Cap
  • VALN 777.9M
  • AVAH 872.6M
  • IPO Year
  • VALN 2021
  • AVAH 2021
  • Fundamental
  • Price
  • VALN $8.94
  • AVAH $8.44
  • Analyst Decision
  • VALN Strong Buy
  • AVAH Buy
  • Analyst Count
  • VALN 4
  • AVAH 5
  • Target Price
  • VALN $15.75
  • AVAH $7.50
  • AVG Volume (30 Days)
  • VALN 129.1K
  • AVAH 1.3M
  • Earning Date
  • VALN 11-06-2025
  • AVAH 11-06-2025
  • Dividend Yield
  • VALN N/A
  • AVAH N/A
  • EPS Growth
  • VALN N/A
  • AVAH N/A
  • EPS
  • VALN N/A
  • AVAH 0.09
  • Revenue
  • VALN $230,566,060.00
  • AVAH $2,177,672,000.00
  • Revenue This Year
  • VALN $15.55
  • AVAH $16.37
  • Revenue Next Year
  • VALN $23.93
  • AVAH $6.62
  • P/E Ratio
  • VALN N/A
  • AVAH $88.97
  • Revenue Growth
  • VALN 25.47
  • AVAH 11.54
  • 52 Week Low
  • VALN $3.62
  • AVAH $3.67
  • 52 Week High
  • VALN $12.25
  • AVAH $8.54
  • Technical
  • Relative Strength Index (RSI)
  • VALN 49.28
  • AVAH 78.92
  • Support Level
  • VALN $8.33
  • AVAH $8.05
  • Resistance Level
  • VALN $9.46
  • AVAH $8.41
  • Average True Range (ATR)
  • VALN 0.35
  • AVAH 0.32
  • MACD
  • VALN -0.15
  • AVAH -0.06
  • Stochastic Oscillator
  • VALN 61.30
  • AVAH 91.23

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About AVAH Aveanna Healthcare Holdings Inc.

Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). Private Duty Services include private duty nursing (PDN) and pediatric therapy services. Revenue is derived from pediatric healthcare services provided to patients including private duty nursing and therapy services, adult home health and hospice services (collectively patient revenue) and from the delivery of enteral nutrition and other products to patients.

Share on Social Networks: